Adderall News and Research

RSS
Adderall (dextroamphetamine-amphetamine) is a combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur.
ADHD patients have increased risk of developing Parkinson's and other similar diseases

ADHD patients have increased risk of developing Parkinson's and other similar diseases

ADHD medications may fail to improve cognition in healthy college students, study shows

ADHD medications may fail to improve cognition in healthy college students, study shows

Graphic: Opioid painkiller is top prescription in 11 states

Graphic: Opioid painkiller is top prescription in 11 states

NIH awards $2 million grant to test effectiveness of nonmedication ADHD treatments

NIH awards $2 million grant to test effectiveness of nonmedication ADHD treatments

Chapman University research explores substance abuse among transgender adolescents in California

Chapman University research explores substance abuse among transgender adolescents in California

ADHD medicines linked to lower risk for substance use problems in adolescents, adults

ADHD medicines linked to lower risk for substance use problems in adolescents, adults

UB researchers explore potential side effects of stimulant drug on people without ADHD

UB researchers explore potential side effects of stimulant drug on people without ADHD

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

U-M study compares early-use and longer-duration stimulant medication with nonstimulant therapy for ADHD

U-M study compares early-use and longer-duration stimulant medication with nonstimulant therapy for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Misuse of Adderall drug rising among young adults, research suggests

Misuse of Adderall drug rising among young adults, research suggests

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Drug use remains stable among teens, MTF survey shows

Drug use remains stable among teens, MTF survey shows

Stimulant medications for ADHD cause sleep problems among children

Stimulant medications for ADHD cause sleep problems among children

Researchers explain why ADHD continues to affect many adults

Researchers explain why ADHD continues to affect many adults

Misuse of prescription drugs common among U.S. college students

Misuse of prescription drugs common among U.S. college students

Shire enters into agreement with Sanquin for CINRYZE

Shire enters into agreement with Sanquin for CINRYZE

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

Teens start misusing ADHD drugs and other stimulants earlier than you might think

Teens start misusing ADHD drugs and other stimulants earlier than you might think

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS

Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS